ThinkEquity
Overview
ThinkEquity is a boutique investment bank created by experienced professionals that have worked together for over a decade, collectively financing over $50 billion of public and private capital raises, restructurings, and mergers and acquisitions. The ThinkEquity model is built around the client's needs, no matter how complicated or around the clock attention required, and to identify solutions that help them to create value for their investors. ThinkEquity provides a suite of services that add value to clients including but not limited to initial public offerings (IPOs), secondary offerings, confidentially marketed public offerings (CMPO), registered directs (RD), at-the-market offerings (ATMs), debt placement and acquisition financing. Their team of professionals have a depth of knowledge and experience creating solutions for growth companies in a variety of sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Alopexx | Jun 2026 | IPO | Lead |
| Medical 21 | Mar 2026 | IPO | Lead |
| Invea Therapeutics | Mar 2026 | IPO | Lead |
| Nova Mineralis S.A. | Dec 2025 | Follow-on Offering | Lead |
| Akston Biosciences Corporation | Oct 2025 | IPO | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.